In this GEN webinar, Mark Perreault will discuss strategies for improving mAb manufacturing using the latest technologies for separating, purifying, and concentrating therapeutic biomolecules.

As monoclonal antibody (mAb) development continues to evolve, new challenges are arising in the purification process, especially during the polishing stage. Innovations in flow-through technology – ...

In some cases, process optimization is required for an existing manufacturing process before process characterization begins. Catalent will share a case study of a monoclonal antibody (mAb) from ...

Scientists working in the bioprocess arena have a lot on their plates lately, including choosing between single-use and stainless steel equipment, integrating processes and instruments, and ...

Researchers at the Institute for Bioscience and Biotechnology (IBBR) in Maryland in the U.S. have taken the first step towards developing a method for the production of a standardized monoclonal ...

The best approach to ensuring scalability of mAb production is to use a platform process rather than focusing on individual project variations, observes the spokesperson from Boehringer Ingelheim.

Unlock the secrets of bioprocessing scale-up through media optimization and commercialization and learn how to tackle common challenges in scaling up mAb manufacturing processes. This insightful ...

NISTmAb, the world's first standardized monoclonal antibody has become a valuable tool for biomanufacturers developing new biologic therapies for cancers, autoimmune disorders and infectious ...

Fujifilm Expands Biopharmaceutical Contract Development and Manufacturing Business, Increasing Monoclonal Antibody Capacity for Process Development and GMP Production at U.S.A. and U.K. Sites ...

DURHAM, N.C., December 03, 2024--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing ...